Animal models for toxoplasma gondii infection

Current Protocols in Immunology

Volumn , Issue SUPPL.96, 2012, Pages

  Subauste, Carlos ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Cytokine; Eye; Parasite; T cell

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PARASITE ANTIGEN; SAG 1 ANTIGEN; SAG 2 ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B1 GENE; BIOLUMINESCENCE; CELLULAR DISTRIBUTION; CHORIORETINITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENCEPHALITIS; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FEMALE; FIBROBLAST; GENE; GROWTH RATE; HISTOPATHOLOGY; HOST PARASITE INTERACTION; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOLECULAR IMAGING; MOUSE; MULTIPHOTON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; T LYMPHOCYTE; TACHYZOITE; TEMPERATURE SENSITIVE MUTANT; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRANSGENIC MOUSE; ADAPTATION; ANIMAL; DISEASE MODEL; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE MUTANT; MUTATION; PARASITOLOGY; TEMPERATURE; TOXOPLASMA; HUMAN;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS; PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIGENS, PROTOZOAN; DISEASE MODELS, ANIMAL; IMMUNIZATION; MICE; MICE, SCID; MUTATION; TEMPERATURE; TOXOPLASMA; TOXOPLASMOSIS; CHORIORETINITIS; ENCEPHALITIS; HUMANS; TOXOPLASMOSIS, ANIMAL;

EID: 45849083923     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1903s96     Document Type: Article

References (65)

1. +) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice. Infect. Immun. 59:1614-1619.
2. Araujo, F.G., Williams, D.M., Grumet, F.C., and Remington, J.S. 1976. Strain-dependent differences in murine susceptibility to toxoplasma. Infect. Immun. 13:1528-1530.
3. Araujo, F.G., Suzuki, Y., and Remington, J.S. 1996. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice. Eur. J. Clin. Microbiol. Infect. Dis. 15:394-397.
4. Beaman, M.H., Araujo, F.G., and Remington, J.S. 1994. Protective reconstitution of the SCID mouse against reactivation of toxoplasmic encephalitis. J. Infect. Dis. 169:375-383.
5. Blackwell, J.M., Roberts, C.W., and Alexander, J. 1993. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: Kinetics of immune regulation inBALBH-2 congenicmice. Parasite Immunol. 15:317-324.
6. Blanchard, N., Gonzalez, F., Schaeffer, M., Joncker, N.T., Cheng, T., Shastri, A.J., Robey,E.A., and Shastri, N. 2008. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat. Immunol. 9:937-944.
7. Bretagne, S., Costa, J.M., Vidaud, M., Tran Van Nhieu, J., and Fleury-Feith, J. 1993. Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J. Infect. Dis. 168:1585-1588.
8. + T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145:3438-3441.
9. Brown, C.R., Hunter, C.A., Estes, R.G., Beckmann, E., Forman, J., David, C., Remington, J.S., and McLeod, R. 1995. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419-428.
10. Buzoni-Gatel, D., Schulthess, J.,Menard, L.C., and Kasper, L.H. 2006. Mucosal defenses against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Cell Microbiol. 8:535-544.
11. Candolfi, E., Hunter, C.A., and Remington, J.S. 1994. Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect. Immun. 62:1995-2001.
12. + gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J. Immunol. 153:4596-4603.
13. Chtanova, T., Han, S.-J., Schaeffer, M., van Dooren, G.G., Herzmark, P., Striepen, B., and Robey, E.A. 2009. Dynamics of T cell, antigenpresenting cell, and pathogen interactions during recall responses in the lymph node. Immunity 31:342-355.
14. Dellacasa-Lindberg, I., Hitziger, N., and Barragan, A. 2007. Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging. Microbes Infect. 9:1291-1298.
15. Denkers, E.Y., Yap, G., Scharton-Kersten, T., Charest, H., Butcher, B., Caspar, P., Hieny, S., and Sher, A. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159:1903-1908.
16. Desmonts, G. and Remington, J.S. 1980. Direct agglutination test for diagnosis of Toxoplasma infection: Method for increasing sensitivity and specificity. J. Clin. Microbiol. 11:562-568.
17. Fox, B.A., and Bzik, D.J. 2002. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 415:926-929.
18. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292.
19. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii J. Immunol. 149:175-180.
20. Gazzinelli, R.T., Eltoum, I., Wynn, T.A., and Sher, A. 1993a. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
21. Gazzinelli, R.T., Hieny, S., Wynn, T.A., Wolf, S., and Sher, A. 1993b. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. U.S.A. 90:6115-6119.
22. Gazzinelli, R.T., Brezin, A., Li, Q., Nussenblatt, R.B., and Chan,C.C. 1994a. Toxoplasma gondii: Acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp. Parasitol. 78:217-229.
23. Gazzinelli, R.T., Wysocka, M., Hayashi, S., Denkers, E.Y., Hieny, S., Caspar, P., Trinchieri, G., and Sher, A. 1994b. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
24. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J. Immunol. 157:798-805.
25. Hisaeda, H., Nagasawa, H., Maeda, K., Maekawa, Y., Ishikawa, H., Ito, Y., Good, R.A., and Himeno, K. 1995. γδ T cells play an important role in hsp65 expression and in acquiring protective immune responses against infection with Toxoplasma gondii. J. Immunol. 154:244-251.
26. Hitziger, N., Dellacasa, I., Albiger, B., and Barragan, A. 2005. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging. Cell. Microbiol. 7:837-848.
27. Howe, D.K. and Sibley, L.D. 1995. Toxoplasma gondii comprises three clonal lineages: Correlation of parasite genotypes with human disease. J. Infect. Dis. 172:1561-1566.
28. Hunter, C.A., Abrams, J.S., Beaman, M.H., and Remington, J.S. 1993. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: Importance of T-cellindependent regulation of resistance to T. gondii. Infect. Immun. 61:4033-4044.
29. Hunter, C.A., Subauste, C.S., van Cleave, V.H., and Remington, J.S. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice:Regulation by interleukin-10, interleukin-12 and tumor necrosis factor alpha. Infect. Immun. 62:2818-2824.
30. Hunter, C.A., Candolfi, E., Subauste, C.S., van Cleave, V., and Remington, J.S. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16-20.
31. + T cell response to intracellular pathogens fails to default to a Th2 pattern and are host protective in an IL-10-/- setting. Immunity 16:429-439.
32. + T cells and dendritic cells during infectionwith Toxoplasma gondii. PLoS Pathogens 5:e1000505.
33. Johnson, A.M. 1984. Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis. Z. Parasitenkd. 70:303-309.
34. Johnson, L.L. 1992a. SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections. Infect. Immun. 60:3719-3724.
35. Johnson, L.L. 1992b. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection. Infect. Immun. 60:1979-1983.
36. + lymphocytes. Infect. Immun. 61:5174-5180.
37. Kasper, L.H., Matsuura, T., and Khan, I.A. 1995. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii. J. Immunol. 155:4798-4804.
38. + T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157:2103-2108.
39. Khan, I.A., Matsuura, T., and Kasper, L.H. 1995. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol. 17:185-195.
40. Kirak, O., Frickel, E.M., Grotenberg,G.M., Suh, H., Jaenisch, R., and Ploegh, H.L. 2010. Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science 328:243-248.
41. Liesenfeld, O., Kosek, J., Remington, J.S., and Suzuki, Y. 1996. Association of CD4+ T cell- dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:597-607.
42. Liu, C.H., Fan,Y.T., Dias,A., Esper, L., Corn, R.A., Bafica, A.,Machado, F.S., and Aliberti, J. 2006. Cutting edge: Dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice.J. Immunol. 177:31-35.
43. McLeod, R., Skamene, E., Brown, C.R., Eisenhauer, P.B., and Mack, D.G. 1989. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AxB/BxA recombinant inbred and B10 congenic mice. J. Immunol. 143:3031-3034.
44. Mennechet, F.J.D., Kasper, L.H., Rachinel, N., Minns, L.A., Luangsay, S.,Vanderwalle, A., and Buzoni-Gatel, D. 2004. Intestinal intraepithelial lymphocytes prevent pathogen-driven inflammation and regulate the Smad/T-bet pathway of lamina propria CD4+ T cells. Eur. J. Immunol. 34:1059-1067.
45. Pepper, M., Dzierszinski, F., Crawford, A., Hunter, C.A., and Roos, D.S. 2004. Development of a system to study CD4+-T cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect. Immun. 72:7240-7246.
46. Portillo, J.-A.C., Okenka, G., Reed, E., Subauste, A., Van Grol, J., Gentil, K., Komatsu, M., Tanaka, K., Landreth, G., Levine, B., and Subauste, C.S. 2010. The CD40-autophagy pathway is needed for host protection despite IFN-γ-dependent immunity and CD40 induces autophagy via control of p21 levels. PloS One e14472.
47. Reichmann, G., Walker, W., Villegas, E.N., Craig, L., Cai, G., Alexander, J., and Hunter, C.A. 2000. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect. Immun. 68:1312-1318.
48. Sayles, P.C., Gibson, G.W., and Johnson, L.L. 2000. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect. Immun. 68:1026-1033.
49. Schaeffer, M., Han, S.-J., Chtanova, T., van Dooren, G.G., Herzmark, P., Chen, Y., Roysam, B., Striepen, B., and Robey, E.A. 2009. Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. J. Immunol. 182:6379-6393.
50. Scharton-Kersten, T.M.,Wynn, T.A., Denkers, E.Y., Bala, S., Grunvald, E., Hieny, S., Gazzinelli, R.T., and Sher, A. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045-4054.
51. Schluter, D., Hein, A., Dorries, R., and Deckert-Schluter, M. 1995. Different subsets of T cells in conjunction with natural killer cells, macrophages, and activated microglia participate in the intracerebral immune response to Toxoplasma gondii in athymic nude and immunocompetent rats. Am. J. Pathol. 146;999-1007.
52. Schluter, D., Meyer, T., Kwok, L.-Y., Montesinos-Rongen, M., Lutjen, S., Strack, A., Schmitz, M.L., and Deckert, M. 2002. Phenotype and regulation of persistent intracerebral T cells in murine Toxoplasma encephalitis. J. Immunol. 169:315-322.
53. Sharma, S., Hofflin, J., andRemington, J.S. 1985. In vivo recombinant IL-2 enhances survival against lethal challenge with T. gondii. J. Immunol. 135:4160-4163.
54. Stumhofer, J.S., Laurence, A., Wilson, E.H., Huang, E., Tato, C.M., Johnson, L.M., Villarino, A.V., Huang, Q., Yoshimura, A., Sehy, D., Saris, C.J., O'Shea, J.J., Hennighausen, L., Ernst, M., and Hunter, C.A. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-945.
55. Subauste, C.S.,Koniaris,A.H., and Remington, J.S. 1991. Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147:3955-3959.
56. + T cells in mice. J. Immunol. 140:3943-3946.
57. Suzuki, Y., Orellana, M.A., Schreiber, R.D., and Remington, J.S. 1988. Interferon-γ: The major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
58. Suzuki, Y., Conley, F.K., and Remington, J.S. 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045-2050.
59. Suzuki, Y., Joh, K., Orellana, M.A., Conley, F.K., and Remington, J.S. 1991. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739.
60. Suzuki, Y., Orellana, M.A., Wong, S.Y., Conley, F.K., and Remington, J.S. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect. Immun. 61:2284-2288.
61. Suzuki, Y., Joh, K., Kwon, O.C., Yang, Q., Conley, F.K., and Remington, J.S. 1994. MHC class I gene(s) in the D/L region but not the TNF-α gene determines development of toxoplasmic encephalitis in mice. J. Immunol. 153:4649-4654.
62. Suzuki, Y., Rani, S., Liesenfeld, O., Kojima, T., Lim, S., Nguyen, T.A., Dalrymple, S.A., Murray, R., and Remington, J.S. 1997. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65:2339-2345.
63. Waldeland, H. and Frenkel, J.K. 1983. Live and killed vaccines against toxoplasmosis in mice. J. Parasitol. 69:60-65.
64. Wilson, E.H., Harris, T.H., Mrass, P., John, B., Tait, E.D., Wu, G.F., Pepper, M., Wherry, E.J., Dzierszinski, F., Roos, D.S., Haydon, P.G., Laufer, T.M., Weninger, W., and Hunter, C.A. 2009. Behaviour of parasite specific effector CD8+ T cells in the CNS and visualization of a kinesis-associated system of reticular fibers. Immunity 30:300-311.
65. + T cells. PLoS Pathogens 19:e1000815.